Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 73.25
+6.15 (9.17%)
At close: Jul 28, 2025, 4:00 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 14.17 billion as of July 28, 2025.
Market Cap
14.17B
Enterprise Value
13.93B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
73.25
Market Cap Chart
Since July 23, 2025, Nanjing Leads Biolabs's market cap has increased from 6.77B to 14.17B, an increase of 109.43%. That is a compound annual growth rate of 27,266,092,971,767,573,000,000,000.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 14.17B | 9.24% |
| Jul 25, 2025 | 12.97B | 91.71% |
| Jul 24, 2025 | 6.77B | - |
| Jul 23, 2025 | 6.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 271.47B |
| Hansoh Pharmaceutical Group Company | 203.94B |
| JD Health International | 154.09B |
| Innovent Biologics | 152.40B |
| Akeso | 133.83B |
| WuXi Biologics | 128.18B |
| Sino Biopharmaceutical | 121.08B |
| CSPC Pharmaceutical Group | 98.67B |